The group A streptococcal vaccine candidate VAX-A1 protects against group B Streptococcusinfection via cross-reactive IgG targeting virulence factor C5a peptidase

Author(s):: McCabe, S.; Bjanes, E.; Hendriks, A.; Wang, Z.; Sorge, N.M. van; Pill-Pepe, L.; Bautista, L.; Chu, E.; Codee, J.D.C. (0000-0003-3531-2138); Fairman, J.; Kapoor, N.; Uchiyama, S.; Nizet, V.

Published: 2023
Publication type: Article / Letter to editor

Date issued: 2023-12-01
Language: English
Is part of: Vaccines (2023), No. 12, 1811
hdl: 1887/3716379
doi: 10.3390/vaccines11121811
URL: https://www.mdpi.com/2076-393X/11/12/1811